(Q35802614)

10 August 2017

The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers (English)

1 reference

10 August 2017

1 reference

1 reference

E J Seaber

1

1 reference

10 August 2017

R W Peck

2

1 reference

10 August 2017

D A Smith

3

1 reference

10 August 2017

J Allanson

4

1 reference

10 August 2017

N R Hefting

5

1 reference

10 August 2017

J J van Lier

6

1 reference

10 August 2017

F A Sollie

7

1 reference

10 August 2017

J Wemer

8

1 reference

10 August 2017

J H Jonkman

9

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

46

1 reference

10 August 2017

5

1 reference

10 August 2017

433-439

1 reference

The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and women.

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873688

Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873688

The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90).

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873688

The pharmacokinetics and effects on blood pressure of multiple doses of the novel anti-migraine drug zolmitriptan (311C90) in healthy volunteers

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873688

311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873688

Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873688

Inhibition of the trigemino-vascular system with 5-HT1D agonist drugs: selectively targeting additional sites of action

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873688

Clinical safety of 311C90: aggregated data from patients and volunteers to date

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873688

The clinical profile of sumatriptan: safety and tolerability

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873688

Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873688

The tolerability and pharmacokinetics of the novel antimigraine compound 311C90 in healthy male volunteers

11 July 2018

1 reference

12 December 2020

Zolmitriptan (Zomig, 311C90), a novel dual central and peripheral 5HT1B/1D agonist: an overview of efficacy

1 reference

12 December 2020

Effect of sumatriptan, a new selective 5HT1-like agonist, on liquid gastric emptying in man

1 reference

12 December 2020

Single dose pharmacokinetics of sumatriptan in healthy volunteers

1 reference

12 December 2020

311C90, a new central and peripherally acting 5-HT1D receptor agonist in the acute oral treatment of migraine: a double-blind, placebo-controlled, dose-range finding study

1 reference

12 December 2020

The clinical effectiveness of 311C90 in the acute treatment of migraine

1 reference

12 December 2020

10.1046/J.1365-2125.1998.00809.X

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

9833595

1 reference